AURA
AURA
NASDAQ · Biotechnology

Aura Biosciences Inc

$6.44
-0.15 (-2.28%)
As of Sep 20, 10:31 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +404.0% upside
Low Target $26.53
Average Target $32.46
High Target $55.40
Current Price $6.44
Current
$6.44
Target
$32.46
$26.53 $32.46 avg $55.40
Scenario Analysis
Bear Case
$26.53
312.0%
Low target
Base Case
$32.46
+404.0%
Avg target
Bull Case
$55.40
+760.2%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$9.54
-32.5% from high
52-Week Low
$4.73
+36.2% from low
Target vs 52W High
$32.46
+240.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%